Short answer
Euglobulin clot lysis time, often shortened to ECLT or ELT, is a specialized test of fibrinolysis: the system that breaks down clots. A shortened lysis time can suggest increased clot breakdown, while a prolonged result can point toward reduced fibrinolytic activity. It is not a routine screening test and is usually interpreted by hematology or a specialized coagulation laboratory.
What the test is trying to answer
| Question | Why ECLT may be used | Important caveat |
|---|---|---|
| Is fibrinolysis excessive? | Rapid clot lysis can contribute to bleeding patterns. | Specimen handling and acute illness can affect interpretation. |
| Is clot breakdown reduced? | Delayed lysis may suggest lower fibrinolytic activity. | It does not identify one protein by itself. |
| Are tPA, PAI-1, plasminogen, or antiplasmin questions relevant? | ECLT can be part of a broader fibrinolysis workup. | Specific assays may be needed for action. |
What short or long results can suggest
- A short ECLT can fit a hyperfibrinolytic pattern, especially when bleeding is delayed or out of proportion to the usual clotting tests.
- A long ECLT can fit reduced fibrinolysis, but method details matter and the number alone is not a diagnosis.
- Because the assay is sensitive to fibrinolysis regulators such as PAI-1, follow-up often needs more specific testing.
Why this is a specialist test
ECLT is technically sensitive and summarizes a pathway rather than giving a single diagnosis. It can overlap with questions about liver disease, trauma, obstetric bleeding, inherited fibrinolysis disorders, medications, and inflammatory states. A result should be read with the bleeding history, PT, aPTT, fibrinogen, D-dimer, plasminogen, alpha-2 antiplasmin, and PAI-1 context when appropriate.
Questions to ask
- Was the concern excessive fibrinolysis, impaired fibrinolysis, or unexplained bleeding?
- Were fibrinogen, D-dimer, plasminogen, alpha-2 antiplasmin, or PAI-1 also measured?
- Could acute illness, liver disease, pregnancy, trauma, or medication use explain the pattern?
- Will the result change treatment, procedure planning, or additional testing?
What follow-up may include
Depending on the lysis pattern, follow-up may include fibrinogen, D-dimer, plasminogen, alpha-2 antiplasmin, PAI-1, liver tests, or a broader bleeding workup. Because this assay is niche, the practical question is usually whether the next test should confirm hyperfibrinolysis, identify a regulator defect, or look for another bleeding explanation entirely.
FAQ
What does euglobulin clot lysis time measure?
It is a global fibrinolysis assay that estimates how quickly a clot breaks down after the euglobulin fraction of plasma has been prepared.
Is this a routine blood test?
No. It is a specialist assay and is usually used only when a clinician is actively thinking about fibrinolysis or unusual bleeding.
What does a short result suggest?
A short result can fit increased clot breakdown, but it still needs clinical context and related fibrinolysis tests.
What does a long result suggest?
A long result can fit reduced fibrinolytic activity, but sample handling and method variation can also matter.
Why do clinicians order other tests too?
Because ECLT does not identify one protein on its own. Follow-up may include fibrinogen, D-dimer, plasminogen, alpha-2 antiplasmin, and PAI-1 testing.
Does normal PT and aPTT rule out a fibrinolysis problem?
No. PT and aPTT tell you about clot formation, not how the clot is later broken down.
Related guides: fibrinogen blood test, D-dimer blood test, plasminogen activity testing, and alpha-2 antiplasmin activity testing.